QST Hospital, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba, 263-8555, Japan.
World J Surg Oncol. 2024 Jul 25;22(1):191. doi: 10.1186/s12957-024-03470-x.
Clear cell odontogenic carcinoma (CCOC) is a rare odontogenic malignant tumor. The standard treatment for CCOC is surgical resection and adjuvant radiotherapy (RT). Radiotherapy is generally considered in inoperable cases. However, there are no reports on definitive RT for CCOC, and the role of RT in patients with inoperable CCOC remains unknown. Therefore, in this report, we present two cases of carbon-ion (C-ion) RT for CCOC.
In case 1, a 73-year-old man with mandibular CCOC presented with recurrence in the inferior temporal fossa after two tumor resections. The tumor was considered inoperable, and C-ion RT (57.6 Gy in 16 fractions) was administered. The tumor remained controlled even after 20 months of C-ion RT; however, the patient died of other causes. In case 2, a 34-year-old man with maxillary CCOC presented with recurrence in the left sinonasal region after two tumor resections. The tumor was considered inoperable, and C-ion RT (64 Gy in 16 fractions) was administered. However, recurrence was observed in the irradiated field 19 months after the treatment. Subsequently, C-ion RT (64 Gy in 16 fractions) was repeated for the recurrent tumors. Seven years and 6 months after the initial irradiation, the tumor remains controlled, and the patient is alive without any unexpected serious adverse events.
C-ion RT may be an effective treatment option for patients with inoperable CCOC.
透明细胞牙源性癌(CCOC)是一种罕见的牙源性恶性肿瘤。CCOC 的标准治疗方法是手术切除和辅助放疗(RT)。一般认为 RT 适用于无法手术的病例。然而,目前尚无关于 CCOC 确定性 RT 的报道,RT 在无法手术的 CCOC 患者中的作用尚不清楚。因此,在本报告中,我们报告了两例 CCOC 的碳离子(C-ion)RT。
在病例 1 中,一名 73 岁男性因下颌 CCOC 复发,在两次肿瘤切除后出现颞下窝复发。肿瘤被认为无法手术,给予 C-ion RT(57.6 Gy 分 16 次)。即使在接受 C-ion RT 20 个月后,肿瘤仍得到控制;然而,患者因其他原因死亡。在病例 2 中,一名 34 岁男性因上颌 CCOC 复发,在两次肿瘤切除后出现左侧鼻窦区域复发。肿瘤被认为无法手术,给予 C-ion RT(64 Gy 分 16 次)。然而,治疗后 19 个月观察到照射野内复发。随后,对复发性肿瘤重复进行 C-ion RT(64 Gy 分 16 次)。初始照射后 7 年 6 个月,肿瘤仍得到控制,患者存活且无任何意外严重不良事件。
C-ion RT 可能是治疗无法手术的 CCOC 患者的有效治疗选择。